Cheah, C., Shanavas, M., Chavez, J., Tong, Y., Li, X. (., Kumar, P., Agarwal, A., Anderson, M. A., Jain, N. (2025). CaDAnCe-104, an ongoing, open-label, phase 1b/2 master protocol study of Bruton tyrosine kinase degrader BGB-16673 in combination with other agents in patients with relapsed/refractory B-cell malignancies. Blood. https://doi.org/10.1182/blood-2025-1839